Table 3 Efficacy and safety outcomes

TICI 2b/3*

4 (100%)

3

2b

2b

2b

Intraprocedural complications*

1 (25%)

–

–

–

ICA-dissection

Final infarct size (ASPECTS 0–10)⁺

7.5 (4–9)

9

8

4

7

Antiplatelet therapy*/starting day

3 (75%)

ASA + Clopidogrel/1d post-OP

ASA/4d post-OP

–

Tirofiban/periinterventional Clopidogrel/1d post-OP

Ventilation duration (h)⁺

265 (34–513)

513

235

34

295

Tracheotomy*

1 (25%)

Yes

–

–

–

Duration of ICU stay (d)⁺

13.5 (2–23)

23

13

2

14

Mortality at day 7*

1 (25%)

–

–

Yes

–

mRS at day 7⁺

5 (5–6)/6 (4–6)

5

5

6

5

Received DNT/DNR order

3 (75%)

No

Yes

No

Yes

mRS at 90 days (0–6)⁺

6 (4–6)

4

6

6

6